Showing results (411-420 of 427) with videos related to
Sort By:
Pageof 43
Plos Genetics|January 8, 2024
SH2 domain protein E and ABL signaling regulate blood vessel sizeJennifer A Schumacher, Zoë A Wright, Diandra Rufin Florat, et al.Journal of the Neurological Sciences|March 19, 2010
Natalizumab plus interferon beta-1a reduces lesion formation in relapsing multiple sclerosisErnst-Wilhelm Radue, William H Stuart, Peter A Calabresi, et al.Nature Communications|January 27, 2023
Gold nanoparticle-enhanced X-ray microtomography of the rodent reveals region-specific cerebrospinal fluid circulation in the brainShelei Pan, Peter H Yang, Dakota DeFreitas, et al.Molecular Cancer Therapeutics|February 28, 2018
EGF Receptor and mTORC1 Are Novel Therapeutic Targets in Nonseminomatous Germ Cell TumorsKenneth S Chen, Nicholas J Fustino, Abhay A Shukla, et al.The Review of Scientific Instruments|November 29, 2014
Monochromatic radiography of high energy density physics experiments on the MAGPIE generatorG N Hall, G C Burdiak, L Suttle, et al.Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]|June 21, 2001
Granulocyte-colony stimulating factor in the prevention of postoperative infectious complications and sub-optimal recovery from operation in patients with colorectal cancer and increased preoperative risk (ASA 3 and 4). Protocol of a controlled clinical trial developed by consensus of an international study group. Part three: individual patient, complication algorithm and quality manageB Stinner, A Bauhofer, W Lorenz, et al.Neurology|September 10, 2003
The utility of MRI in suspected MS [RETIRED]: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of NeurologyE M Frohman, D S Goodin, P A Calabresi, et al.Journal of Neurology|March 25, 2009
The efficacy of natalizumab in patients with relapsing multiple sclerosis: subgroup analyses of AFFIRM and SENTINELMichael Hutchinson, Ludwig Kappos, Peter A Calabresi, et al.Neurology|November 26, 2003
Contrast letter acuity as a visual component for the Multiple Sclerosis Functional CompositeL J Balcer, M L Baier, J A Cohen, et al.Neurology|September 1, 2007
The incidence and significance of anti-natalizumab antibodies: results from AFFIRM and SENTINELP A Calabresi, G Giovannoni, C Confavreux, et al.Pageof 43